Increased levels of the stress neurotransmitter noradrenaline were previously reported in nicotine-treated NSCLC cells, leading to increased cell proliferation that was reversed by cell treatment with either the α7nAChR antagonist (α-BTX), or the β-blocker (propranolol) [23]. The gene discussed is CHRNA7; the disease is non-small cell lung carcinoma.